NFkappaB polymorphisms and susceptibility to type 1 diabetes

Genes and Immunity
D M HegazyA G Demaine

Abstract

Nuclear factor kappa B (NFkappaB) is an important transcription factor that is involved in the response to oxidative stress and inflammation. Recent studies suggest that it may be involved in the development of diabetic microvascular complications. A highly polymorphic (CA) dinucleotide repeat microsatellite has been identified in the regulatory region of the NFkappaB gene. The aim of this study was to investigate whether this polymorphic region was associated with susceptibility to type 1 diabetes, or its late complications. Genomic DNA was extracted from the peripheral blood of 217 patients with type 1 diabetes mellitus (T1DM) and 111 normal healthy controls. In our population 18 alleles (A1-A18) were identified. There was a highly significant decrease in the frequency of allele 146 bp (A14) in type 1 diabetes (0.03) compared with the normal controls (0.28) (chi(2) = 79.8, Pc = 0.00001). In contrast, the frequency of the allele 138 bp (A10) was significantly increased in patients with type 1 diabetes (0.17) compared with the normal controls (0.02) (chi(2) = 32.8, P < 0.00000). These results demonstrate that the NFkappaB gene may play a role in the susceptibility to type 1 diabetes: individuals with the A10 allele may be more ...Continue Reading

References

Mar 5, 1987·The New England Journal of Medicine·D A GreeneA A Sima
Sep 12, 1995·Proceedings of the National Academy of Sciences of the United States of America·J A Todd
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Jun 1, 1993·Diabetes·J R WilliamsonR G Tilton
Apr 1, 1996·The Journal of Clinical Investigation·K BrandD Neumeier
Jun 1, 1996·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·T R Merriman, J A Todd
Oct 4, 1996·Cell·P A Baeuerle, D Baltimore
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Mar 9, 1999·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·V PravicaI V Hutchinson

❮ Previous
Next ❯

Citations

Apr 5, 2005·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Manyu LiCong-Yi Wang
Jul 14, 2012·Current Diabetes Reports·Bernd BaumannBernhard O Boehm
Apr 1, 2004·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Stanford L Peng
Nov 14, 2003·Clinical Nutrition : Official Journal of the European Society of Parenteral and Enteral Nutrition·A Paoloni-GiacobinoC Pichard
May 22, 2010·Nature Reviews. Drug Discovery·Denise Faustman, Miriam Davis
Feb 25, 2005·Genes and Immunity·R Kosoy, P Concannon
Aug 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Liqin BanDenise L Faustman
Nov 8, 2008·Proceedings of the National Academy of Sciences of the United States of America·Won Ho YangJin Won Cho
Aug 20, 2011·BMC Medical Genetics·Ingeborg BrønstadEystein S Husebye
Jun 9, 2004·European Journal of Immunogenetics : Official Journal of the British Society for Histocompatibility and Immunogenetics·B RuedaJ Martín
Apr 8, 2014·BioMed Research International·Y M OltuluI Yaylim
May 8, 2018·Journal of Molecular Endocrinology·Kira MeyerovichAlessandra K Cardozo
Nov 20, 2018·British Journal of Neurosurgery·Idris KınaTurgut Ulutin
May 5, 2018·Frontiers in Immunology·Sujuan YangSong Guo Zheng
Aug 13, 2002·Current Opinion in Clinical Nutrition and Metabolic Care·Robert F Grimble
May 23, 2013·Basic & Clinical Pharmacology & Toxicology·Nil ÖzbilümEylem Itir Aydemir

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.